These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2194894)

  • 1. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon.
    Mathus-Vliegen EM; Tytgat GN; Veldhuyzen-Offermans EA
    Gastroenterology; 1990 Aug; 99(2):362-9. PubMed ID: 2194894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up.
    Mathus-Vliegen EM; Tytgat GN
    Gastrointest Endosc; 2005 Jan; 61(1):19-27. PubMed ID: 15672051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.
    Genco A; Cipriano M; Bacci V; Cuzzolaro M; Materia A; Raparelli L; Docimo C; Lorenzo M; Basso N
    Int J Obes (Lond); 2006 Jan; 30(1):129-33. PubMed ID: 16189503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour pH measurements in morbid obesity: effects of massive overweight, weight loss and gastric distension.
    Mathus-Vliegen LM; Tytgat GN
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):635-40. PubMed ID: 8853250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension.
    Mathus-Vliegen EM; Tygat GN
    Scand J Gastroenterol; 2002 Nov; 37(11):1246-52. PubMed ID: 12465720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.
    Ponce J; Woodman G; Swain J; Wilson E; English W; Ikramuddin S; Bour E; Edmundowicz S; Snyder B; Soto F; Sullivan S; Holcomb R; Lehmann J;
    Surg Obes Relat Dis; 2015; 11(4):874-81. PubMed ID: 25868829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragastric balloons for morbid obesity: results, patient tolerance and balloon life span.
    Mathus-Vliegen EM; Tytgat GN
    Br J Surg; 1990 Jan; 77(1):76-9. PubMed ID: 2302519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric distension, hunger and energy intake after balloon implantation in severe obesity.
    Rigaud D; Trostler N; Rozen R; Vallot T; Apfelbaum M
    Int J Obes Relat Metab Disord; 1995 Jul; 19(7):489-95. PubMed ID: 8520639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, sham-controlled trial of the gastric bubble for obesity.
    Hogan RB; Johnston JH; Long BW; Sones JQ; Hinton LA; Bunge J; Corrigan SA
    Gastrointest Endosc; 1989; 35(5):381-5. PubMed ID: 2792672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind controlled trial of the Garren-Edwards gastric bubble: an adjunctive treatment for exogenous obesity.
    Benjamin SB; Maher KA; Cattau EL; Collen MJ; Fleischer DE; Lewis JH; Ciarleglio CA; Earll JM; Schaffer S; Mirkin K
    Gastroenterology; 1988 Sep; 95(3):581-8. PubMed ID: 3294079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss.
    Sullivan S; Swain J; Woodman G; Edmundowicz S; Hassanein T; Shayani V; Fang JC; Noar M; Eid G; English WJ; Tariq N; Larsen M; Jonnalagadda SS; Riff DS; Ponce J; Early D; Volckmann E; Ibele AR; Spann MD; Krishnan K; Bucobo JC; Pryor A
    Surg Obes Relat Dis; 2018 Dec; 14(12):1876-1889. PubMed ID: 30545596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity.
    Marshall JB; Schreiber H; Kolozsi W; Vasudeva R; Bacon BR; McCullough AJ; Holt S
    Am J Gastroenterol; 1990 Jul; 85(7):833-7. PubMed ID: 2196784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric emptying of solids in morbid obesity.
    Tosetti C; Corinaldesi R; Stanghellini V; Pasquali R; Corbelli C; Zoccoli G; Di Febo G; Monetti N; Barbara L
    Int J Obes Relat Metab Disord; 1996 Mar; 20(3):200-5. PubMed ID: 8653139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gastric bubble as a weight reduction device: a controlled, crossover study.
    Meshkinpour H; Hsu D; Farivar S
    Gastroenterology; 1988 Sep; 95(3):589-92. PubMed ID: 3294080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.
    Courcoulas A; Abu Dayyeh BK; Eaton L; Robinson J; Woodman G; Fusco M; Shayani V; Billy H; Pambianco D; Gostout C
    Int J Obes (Lond); 2017 Mar; 41(3):427-433. PubMed ID: 28017964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a balanced energy and high protein formula diet (Vegestart complet®) vs. low-calorie regular diet in morbid obese patients prior to bariatric surgery (laparoscopic single anastomosis gastric bypass): a prospective, double-blind randomized study.
    Carbajo MA; Castro MJ; Kleinfinger S; Gómez-Arenas S; Ortiz-Solórzano J; Wellman R; García-Ianza C; Luque E
    Nutr Hosp; 2010; 25(6):939-48. PubMed ID: 21519764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragastric balloons in comparison with standard therapy for obesity--a randomized, double-blind trial.
    Lindor KD; Hughes RW; Ilstrup DM; Jensen MD
    Mayo Clin Proc; 1987 Nov; 62(11):992-6. PubMed ID: 3312857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
    Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
    Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese subjects: a double-blind comparative study.
    De Castro ML; Morales MJ; Del Campo V; Pineda JR; Pena E; Sierra JM; Arbones MJ; Prada IR
    Obes Surg; 2010 Dec; 20(12):1642-6. PubMed ID: 20390374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.
    Hollenbach M; Prettin C; Gundling F; Schepp W; Seufert J; Stein J; Rösch T; Aberle J; Feisthammel J; Petroff D; Hoffmeister A
    BMC Gastroenterol; 2018 Jul; 18(1):118. PubMed ID: 30021518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.